Isolation and optimization of Bacillus subtilis SH21 for low purine and high nattokinase activity

  • PANG Yuanxiang ,
  • XIE Yuanhong ,
  • JIN Junhua ,
  • LIU Hui ,
  • ZHANG Hongxing
Expand
  • (Food Science and Engineering College,Beijing University of Agriculture,Beijing Laboratory of Food Quality and Safety,Beijing Key Laboratory of Detection and Control of Spoilage Organisms and Pesticide Residues in Agricultural Products,Beijing 102206,China)

Received date: 2020-10-29

  Revised date: 2020-11-17

  Online published: 2021-07-16

Abstract

A strain with high nattokinase activity was screened from naturally fermented pastes with casein plate selecting and shaking culturing, the strain SH21 was identified as Bacillus subtilis by 16S rRNA gene sequencing. Using nattokinase activity (NK) and purine as indicators, the liquid fermentation conditions of Bacillus subtilis SH21 were optimized by single factor experiments and response surface methodology. The single factor tests were designed to investigate the influence of carbon sources, nitrogen sources, pH, inoculation, fermentation temperature and fermentation time on nattokinase activity and purine content. Then the Plackett-Burman test was designed, and three significant factors, pH, inoculation and fermentation temperature were obtained. Finally, the Box-Behnken design was used and the response surface analysis was performed. The optimized fermentation condition was pH 6.0, with the inoculation amount 3%, and fermentation temperature 38℃. The enzyme activity increased from 166.99 U/mL to 204.52 U/mL, which was improved by 1.22 folds. While the purine content decreased from 75.4 mg/L to 51.27 mg/L, reduced by 32% under the optimized condition. This study lays the foundation for the further development of B. subtilis fermentation products with high nattokinase activity and low purine production.

Cite this article

PANG Yuanxiang , XIE Yuanhong , JIN Junhua , LIU Hui , ZHANG Hongxing . Isolation and optimization of Bacillus subtilis SH21 for low purine and high nattokinase activity[J]. Food and Fermentation Industries, 2021 , 47(11) : 194 -199 . DOI: 10.13995/j.cnki.11-1802/ts.026039

References

[1] CHEN H J,MCGOWAN E M,REN N N,et al.Nattokinase:A promising alternative in prevention and treatment of cardiovascular diseases[J].Biomarker Insights,2018,13(13).DOI:10.1177/1177271918785130.
[2] LEE D L,HONG S Y,JANG Y S,et al.The evaluation of antithrombotic and fibrinolytic activities of nattokinase from Bacillus subtilis natto[J].KSBB Journal,2012,27(6):375-380.
[3] MILNER M,MAKISE K.Natto and its active ingredient nattokinase:A potent and safe thrombolytic agent[J].Alternative and Complementary therapies,2002,8(3):157-164.
[4] XU J P,DU M,YANG X L,et al.Thrombolytic effects in vivo of nattokinase in a carrageenan-induced rat model of thrombosis[J].Acta Haematologica,2014,132(2):247-253.
[5] JENSEN G S,LENNINGER M,ERO M P,et al.Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor,a cardiovascular risk marker:Results from a randomized,double-blind,placebo-controlled,multicenter North American clinical trial[J].Integrated Blood Pressure Control,2016,9:95-104.
[6] FUJITA M,OHNISHI K,TAKAOKA S,et al.Antihypertensive effects of continuous oral administration of nattokinase and its fragments in spontaneously hypertensive rats[J].Biological and Pharmaceutical Bulletin,2011,34(11):1 696-1 701.
[7] BHATT P C,PATHAK S,KUMAR V,et al.Attenuation of neurobehavioral and neurochemical abnormalities in animal model of cognitive deficits of Alzheimer's disease by fermented soybean nanonutraceutical[J].Inflammopharmacology,2018,26(2):105-118.
[8] HAMZA A.Miracle enzymes serrapeptase and nattokinase mitigate neuroinflammation and apoptosis associated with Alzheimer's disease in experimental model[J].World Journal of Pharmacy and Pharmaceutical Sciences,2014,3(2):876-891.
[9] TYAGI M G.Nattokinase enzyme;An evaluation of its cellular and potential therapeutic actions[J].European Journal of Pharmaceutical and Medical Research,2016,1(18):411-414.
[10] 尹潍. 高尿酸血症和痛风[J].国外医学(内分泌学分册),2003,23(4):219-221.
YIN W.The hyperuricemia and gout[J].Foreign Medical Sciences (Section of Endocrinology),2003,23(4):219-221.
[11] MAN L L,XIANG D J,ZHANG C L.Strain screening from traditional fermented soybean foods and induction of nattokinase production in Bacillus subtilis MX-6[J].Probiotics and Antimicrobial Proteins,2019,11(1):283-294.
[12] HUA Y,JIANG B,MINE Y,et al.Purification and characterization of a novel fibrinolytic enzyme from Bacillus sp. nov.SK006 isolated from an Asian traditional fermented shrimp paste[J].Journal of Agricultureal and Food Chemistry,2008,56(4):1 451-1 457.
[13] WONG A H K,MINE Y.Novel fibrinolytic enzyme in fermented shrimp paste,a traditional Asian fermented seasoning[J].Journal of Agricultural and Food Chemistry,2004,52(4):980-986.
[14] DUBEY R,KUMAR J,AGRAWALA D,et al.Isolation,production,purification,assay and characterization of fibrinolytic enzymes (nattokinase,streptokinase and urokinase) from bacterial sources[J].African Journal of Biotechnology,2011,10(3):1 408-1 420.
[15] LI S P,LI P,LAI C M,et al.Simultaneous determination of ergosterol,nucleosides and their bases from natural and cultured Cordyceps by pressurised liquid extraction and high-performance liquid chromatography[J].Journal of Chromatography A,2004,1 036(2):239-243.
[16] 鲁洋,钱和,张伟国.低嘌呤、高酶活纳豆芽孢杆菌液态发酵条件的优化[J].食品工业科技,2014,35(18):221-224;235.
LU Y,QIAN H,ZHANG W G.Optimization of Bacillus natto liquid fermentation for low purine and high enzyme activity[J].Science and Technology of Food Industry,2014,35(18):221-224;235.
[17] DABBAGH F,NEGAHDARIPOUR M,BERENJIAN A,et al.Nattokinase:production and application[J].Applied Microbiology and Biotechnology,2014,98(22):9 199-9 206.
[18] 冒鑫哲,彭政,周冠宇,等.枯草芽孢杆菌高产角蛋白酶发酵条件优化[J].食品与发酵工业,2020,46(17):138-144.
MAO X Z,PENG Z,ZHOU G Y,et al.Optimized fermentation for improving keratinase production by Bacillus subtilis WB600[J].Food and Fermentation Industries,2020,46(17):138-144.
Outlines

/